Release of soluble CD40 ligand after platelet activation: Studies on the solubilization phase

Thrombosis Research

Volumn 114, Issue 3, 2004, Pages 167-177

  Otterdal, Kari ^a   Pedersen, Turid Margrethe ^a   Solum, Nils Olav ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

TG; thromboglobulin; ACD; citric acid, citrate, dextrose; EDTA; ethylenediaminetetraacetate; HEPES; MAb; MFI; monoclonal antibody; N 2 hydroxyethylpiperazine N 2 ethanesulfonic acid; PE; phycoerythrin; Platelet; sCD40L; SFLLRN

Indexed keywords

ABCIXIMAB; CD40 LIGAND; CYTOCHALASIN D; EDETIC ACID; FIBRINOGEN; MONOCLONAL ANTIBODY; PROSTAGLANDIN E1;

ALKALINIZATION; ARTICLE; CELL STIMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; GLANZMANN DISEASE; HUMAN; HUMAN CELL; INCUBATION TIME; PRIORITY JOURNAL; SOLUBILIZATION; THROMBOCYTE ACTIVATION; THROMBOCYTE RICH PLASMA; ULTRACENTRIFUGATION;

BLOOD PLATELETS; CD40 LIGAND; CELLS, CULTURED; HUMANS; PHASE TRANSITION; PLATELET ACTIVATION; SOLUBILITY; THROMBASTHENIA;

EID: 4444283150     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.05.007     Document Type: Article

References (25)

1. Armitage R.J., Fanslow W.C., Strockbine L., Sato T.A., Clifford K.N., Macduff B.M., et al. Molecular and biological characterization of a murine ligand for CD40. Nature. 357:1992;80-82
2. Graf D., Korthauer G.D., Mages H.W., Senger G., Kroczek R.A. Cloning of TRAP, a ligand for CD40 on human T cells. Eur. J. Immunol. 22:1992;3191-3194
3. van Kooten C., Banchereau J. CD40-CD40 ligand. J. Leukoc. Biol. 67:2000;2-17
4. Spriggs M.K., Armitage R.J., Strockine L., Clifford K.N., Macduff B.M., Sato T.A., et al. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176:1992;1543-1550
5. Kroczek R.A., Graf D., Brugnoni D., Giliani S., Korthäuer U., Ugazio A., et al. Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)" Immunol. Rev. 138:1994;39-59
6. Gauchat J.F., Henchoz S., Mazzei G., Aubry J.P., Brunner T., Blasey H., et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature. 365:1993;340-343
7. Gauchat J.F., Henchoz S., Fattah D., Mazzei G., Aubry J.P., Jomotte T., et al. CD40 ligand is functionally expressed on human eosinophils. Eur. J. Immunol. 25:1995;863-865
8. Henn V., Slupsky J.R., Gräfe M., Anagnostopoulos I., Förster R., Müller-Berghaus G., et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 391:1998;591-594
9. Hermann A., Rauch B.H., Braun M., Schrör K., Weber A.-A. Platelet CD40 ligand - subcellullar localization, regulation of expression, and inhibition by clopidogrel. Platelets. 12:2001;74-82
10. Aukrust P., Müller F., Ueland T., Berget T., Aaser E., Brunsvig A., et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation. 100:1999;614-620
11. Henn V., Steinbach S., Buchner K., Presek P., Kroczek R.A. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood. 98:2001;1047-1054
12. Jin Y., Nonoyama S., Morio T., Imai K., Ochs H., Mizutani S. Characterization of soluble CD40 ligand released from human activated platelets. J. Med. Dent. Sci. 48:2001;23-27
13. Yellin M.J., Sippel K., Inghirami G., Covey L.R., Lee J.J., Sinning J., et al. CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L: potential role in regulating helper effector function. J. Immunol. 152:1994;598-608
14. Ludewig B., Henn V., Schröder J.M., Graf D., Kroczek R.A. Induction, regulation, and function of soluble TRAP (CD40 ligand) during interaction of primary CD4+CD45RA+T cells with dendritic cells. Eur. J. Immunol. 26:1996;3137-3143
15. Graf D., Müller S., Korthauer U., van Kooten C., Weise C., Kroczek R.A. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur. J. Immunol. 25:1995;1749-1754
16. Fanslow W.C., Srinivasan S., Paxton R., Gibson M.G., Spriggs M.K., Armitage R.J. Structural characteristics of CD40 ligand that determine biological function. Semin. Immunol. 6:1994;267-278
17. Otterdal K., Pedersen T.M., Solum N.O. Platelet shape change induced by the peptide YFLLRNP. Thromb. Res. 103:2001;411-420
18. Nannizzi-Alaimo L., Rubenstein M.H., Alves V.L., Leong G.Y., Phillips D.R., Gold H.K. Cardiopulmonary bypass induces release of soluble CD40 ligand. Circulation. 105:2002;2849-2854
19. Wang C.-L., Wu Y.-T., Liu C.A., Lin M.-W., Lee C.-J., Huang L.-T., et al. Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki Disease. Pediatrics. 111:2003;140-147
20. Inwald D.P., McDowall A., Peters M.J., Callard R.E., Klein N.J. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ. Res. 92:2003;1041-1048
21. Shurety W., Paga J.K., Prins J.B., Stow J.L. Endocytosis of uncleaved tumor necrosis factor-α in macrophages. Lab. Invest. 81:2001;107-117
22. Wang X.-F., Liu F., Morris S.A., Carrol R.C. Synergistic outside-in regulation of platelet activation by GPIIb-IIIa ligand induced conformation and oligomerization. Thromb. Res. 104:2001;239-247
23. Nannizi-Alaimo L., Alves V.L., Phillips D.R. Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation. Circulation. 107:2003;1123-1128
24. 3 integrin-dependent mechanism. Nat. Med. 8:2002;247-252
25. 3. Thromb. Haemost. 78:1997;220-225